Wateba, Mi <br/><br/>
[Intrathecal therapy with 1 500 UI of antitetanic serum and 1.5 g of intravenous metronidazole: prognosis of tetanus in hospitalized patients in Togo].  [electronic resource] 

 -  Sante (Montrouge, France)   
 - 125-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; English Abstract; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1157-5999 
<br/><br/><label>Standard No.: </label>10.1684/san.2008.0115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Infective Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Data Interpretation, Statistical<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Injections, Intramuscular<br/>Injections, Intravenous<br/>Injections, Spinal<br/>Male<br/>Metronidazole--administration & dosage<br/>Middle Aged<br/>Prognosis<br/>Prospective Studies<br/>Tetanus--mortality<br/>Tetanus Antitoxin--administration & dosage<br/>Togo<br/>Treatment Outcome